The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Role of Functional Imaging in the Management of Lymphoma
Abstract
18-F-fluorodeoxyglucose (FDG) –positron emission tomography (PET), and more recently PET/computed tomography (CT), is the most sensitive and specific imaging technique currently available for patients with lymphoma. Nevertheless, despite being increasingly used in pretreatment assessment, midtreatment evaluation of response, post-treatment restaging, and surveillance during follow-up of patients with lymphoma, its impact on clinical outcome in most clinical situations remains to be confirmed. PET/CT provides its greatest clinical benefit in the post-treatment evaluation of Hodgkin's lymphoma and diffuse large B-cell lymphoma; however, the role of metabolic imaging in other indications and in other histologies remains to be demonstrated. Ongoing risk-adapted studies will hopefully provide evidence for clinical improvement on the basis of altering treatment as a result of interim PET results. Efforts are ongoing to better standardize the conduct and interpretation of FDG-PET scans. FDG-PET has the potential to improve lymphoma patient management; however, its usefulness will likely vary by histology, stage, therapy, and clinical setting.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Predictive Model for Aggressive Non-Hodgkin's Lymphoma
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291402 · Cited by 4,949
Revised Response Criteria for Malignant Lymphoma
Cheson, B. D., Pfistner, B., Juweid, M. E., Gascoyne, R. D., Specht, L., Horning, S. J., Coiffier, B., Fisher, R. I., Hagenbeek, A., Zucca, E., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.2403 · Cited by 4,426
Self-citationReport of the Committee on Hodgkin's Disease Staging Classification.
Carbone, P. P., Kaplan, H. S., Musshoff, K., Smithers, D. W., & Tubiana, M. (1971) · PubMed · Cited by 4,166
Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas
Cheson, B. D., Horning, S. J., Coiffier, B., Shipp, M. A., Fisher, R. I., Connors, J. M., Lister, T. A., Vose, J., Grillo-López, A., Hagenbeek, A., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.4.1244 · Cited by 3,486
Self-citationStromal Gene Signatures in Large-B-Cell Lymphomas
Lenz, G., Wright, G., Dave, S. S., Xiao, W., Powell, J., Zhao, H., Xu, W., Tan, B., Goldschmidt, N., Iqbal, J., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802885 · Cited by 1,808
A Prognostic Score for Advanced Hodgkin's Disease
Hasenclever, D., Diehl, V., Armitage, J. O., Assouline, D., Björkholm, M., Brusamolino, E., Canellos, G. P., Carde, P., Crowther, D., Cunningham, D., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199811193392104 · Cited by 1,736
Lister, T. A., Crowther, D., Sutcliffe, S. B., Glatstein, E., Canellos, G. P., Young, R. C., Rosenberg, S. A., Coltman, C. A., & Tubiana, M. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.11.1630 · Cited by 1,639
Follicular lymphoma international prognostic index
Solal-Celigny, P. (2006) · Current Treatment Options in Oncology · doi:10.1007/s11864-006-0036-3 · Cited by 1,339
Juweid, M. E., Stroobants, S., Hoekstra, O. S., Mottaghy, F. M., Dietlein, M., Guermazi, A., Wiseman, G. A., Kostakoglu, L., Scheidhauer, K., Buck, A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.2305 · Cited by 1,335
Self-citationGallamini, A., Hutchings, M., Rigacci, L., Specht, L., Merli, F., Hansen, M., Patti, C., Loft, A., Di Raimondo, F., D'Amore, F., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.6525 · Cited by 846
Report on the First International Workshop on interim-PET scan in lymphoma
Meignan, M., Gallamini, A., Meignan, M., Gallamini, A., & Haioun, C. (2009) · Leukemia & Lymphoma · doi:10.1080/10428190903040048 · Cited by 754
Hutchings, M., Loft, A., Hansen, M., Pedersen, L. M., Buhl, T., Jurlander, J., Buus, S., Keiding, S., D'Amore, F., Boesen, A.-M., et al. (2006) · Blood · doi:10.1182/blood-2005-06-2252 · Cited by 726
Follicular Lymphoma International Prognostic Index
Solal-Celigny, P. (2004) · Blood · doi:10.1182/blood-2003-12-4434 · Cited by 626
Jerusalem, G., Beguin, Y., Fassotte, M. F., Najjar, F., Paulus, P., Rigo, P., & Fillet, G. (1999) · Blood · doi:10.1182/blood.v94.2.429 · Cited by 565
Gallagher, B. M., Fowler, J. S., Gutterson, N. I., MacGregor, R. R., Wan, C.-N., & Wolf, A. P. (1978) · PubMed · Cited by 557
Haioun, C., Itti, E., Rahmouni, A., Brice, P., Rain, J.-D., Belhadj, K., Gaulard, P., Garderet, L., Lepage, E., Reyes, F., et al. (2005) · Blood · doi:10.1182/blood-2005-01-0272 · Cited by 494
Schöder, H., Noy, A., Gönen, M., Weng, L., Green, D., Erdi, Y. E., Larson, S. M., & Yeung, H. W. D. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.12.072 · Cited by 491
Spaepen, K., Stroobants, S., Dupont, P., Van Steenweghen, S., Thomas, J., Vandenberghe, P., Vanuytsel, L., Bormans, G., Balzarini, J., De Wolf-Peeters, C., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.414 · Cited by 465
Utility of FDG-PET scanning in lymphoma by WHO classification
Elstrom, R., Guan, L., Baker, G., Nakhoda, K., Vergilio, J.-A., Zhuang, H., Pitsilos, S., Bagg, A., Downs, L., Mehrotra, A., et al. (2003) · Blood · doi:10.1182/blood-2002-09-2778 · Cited by 437
Spaepen, K., Stroobants, S., Dupont, P., Vandenberghe, P., Thomas, J., de Groot, T., Balzarini, J., De Wolf-Peeters, C., Mortelmans, L., & Verhoef, G. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf256 · Cited by 410
Mikhaeel, N. G., Hutchings, M., Fields, P. A., O'Doherty, M. J., & Timothy, A. R. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi272 · Cited by 401
Lin, C., Itti, E., Haioun, C., Petegnief, Y., Luciani, A., Dupuis, J., Paone, G., Talbot, J.-N., Rahmouni, A., & Meignan, M. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.042093 · Cited by 394
Juweid, M. E., Wiseman, G. A., Vose, J. M., Ritchie, J. M., Menda, Y., Wooldridge, J. E., Mottaghy, F. M., Rohren, E. M., Blumstein, N. M., Stolpen, A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.891 · Cited by 387
Self-citationYEUNG, H. W. D., Grewal, R. K., Gönen, M., Schöder, H. M., & Larson, S. M. (2003) · PubMed · Cited by 370
Schaefer, N. G., Hany, T. F., Taverna, C., Seifert, B., Stumpe, K. D. M., von Schulthess, G. K., & Goerres, G. W. (2004) · Radiology · doi:10.1148/radiol.2323030985 · Cited by 364
Barrington, S. F., Qian, W., Somer, E. J., Franceschetto, A., Bagni, B., Brun, E., Almquist, H., Loft, A., Højgaard, L., Federico, M., et al. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1490-5 · Cited by 348
Prognostic value of interim FDG-PET after two or three cycles of chemotherapy in Hodgkin lymphoma
Hutchings, M., Mikhaeel, N. G., Fields, P. A., Nunan, T., & Timothy, A. R. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi200 · Cited by 327
Moskowitz, C. H., Schöder, H., Teruya-Feldstein, J., Sima, C., Iasonos, A., Portlock, C. S., Straus, D., Noy, A., Palomba, M. L., O'Connor, O. A., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.5942 · Cited by 326
Detection of Lymphoma in Bone Marrow by Whole-Body Positron Emission Tomography
Carr, R., Barrington, S. F., Madan, B., O'Doherty, M. J., Saunders, C. A. B., van der Walt, J., & Timothy, A. R. (1998) · Blood · doi:10.1182/blood.v91.9.3340 · Cited by 324
Gallamini, A., Rigacci, L., Merli, F., Nassi, L., Bosi, A., Capodanno, I., Luminari, S., Vitolo, U., Sancetta, R., Iannitto, E., et al. (2006) · PubMed · Cited by 314
Moog, F., Bangerter, M., Kotzerke, J., Guhlmann, A., Frickhofen, N., & Reske, S. N. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.2.603 · Cited by 277
Jerusalem, G., Beguin, Y., Najjar, F., Hustinx, R., Fassotte, M. F., Rigo, P., & Fillet, G. (2001) · Annals of Oncology · doi:10.1023/a:1011169332265 · Cited by 268
Imaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose: correlation with CT.
Newman, J. S., Francis, I. R., Kaminski, M. S., & Wahl, R. L. (1994) · Radiology · doi:10.1148/radiology.190.1.8259386 · Cited by 265
18F-FDG PET for evaluation of bone marrow infiltration in staging of lymphoma: a meta-analysis.
Pakos, E. E., FOTOPOULOS, A. D., & Ioannidis, J. P. A. (2005) · PubMed · Cited by 256
Terasawa, T., Lau, J., Bardet, S., Couturier, O., Hotta, T., Hutchings, M., Nihashi, T., & Nagai, H. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.0861 · Cited by 254
Bangerter, M., Moog, F., Buchmann, I., Kotzerke, J., Griesshammer, M., Hafner, M., Elsner, K., Frickhofen, N., Reske, S. N., & Bergmann, L. (1998) · Annals of Oncology · doi:10.1023/a:1008486928190 · Cited by 244
Buchmann, I., Reinhardt, M., Elsner, K., Bunjes, D., Altehoefer, C., Finke, J., Moser, E., Glatting, G., Kotzerke, J., Guhlmann, C. A., et al. (2001) · Cancer · doi:10.1002/1097-0142(20010301)91:5<889::aid-cncr1078>3.0.co;2-5 · Cited by 239
Spaepen, K., Stroobants, S., Dupont, P., Vandenberghe, P., Maertens, J., Bormans, G., Thomas, J., Balzarini, J., De Wolf-Peeters, C., Mortelmans, L., et al. (2003) · Blood · doi:10.1182/blood-2002-12-3842 · Cited by 226
Jérusalem, G., Beguin, Y. P., Fassotte, M., Najjar, F., Paulus, P., Rigo, P., & Fillet, G. (2001) · PubMed · Cited by 218
Jerusalem, G., Beguin, Y., Fassotte, M. F., Belhocine, T., Hustinx, R., Rigo, P., & Fillet, G. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg011 · Cited by 215
Kostakoglu, L., Leonard, J. P., Kuji, I., Coleman, M., Vallabhajosula, S., & Goldsmith, S. J. (2002) · Cancer · doi:10.1002/cncr.10336 · Cited by 212
Naumann, R., Vaic, A., Beuthien‐Baumann, B., Bredow, J., Kropp, J., Kittner, T., Franke, W., & Ehninger, G. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.03147.x · Cited by 212
Jerusalem, G., Beguin, Y. P., Fassotte, M., Najjar, F., Paulus, P., Rigo, P., & Fillet, G. (2000) · PubMed · Cited by 203
Sugawara, Y., Fisher, S. J., Zasadny, K. R., Kison, P. V., Baker, L. H., & Wahl, R. L. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.1.173 · Cited by 199
Tsukamoto, N., Kojima, M., Hasegawa, M., Oriuchi, N., Matsushima, T., Yokohama, A., Saitoh, T., Handa, H., Endo, K., & Murakami, H. (2007) · Cancer · doi:10.1002/cncr.22807 · Cited by 193
Molecular Imaging of Proliferation in Malignant Lymphoma
Buck, A. K., Bommer, M., Stilgenbauer, S., Juweid, M., Glatting, G., Schirrmeister, H., Mattfeldt, T., Tepsic, D., Bunjes, D., Mottaghy, F. M., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1955 · Cited by 185
The role of positron emission tomography (PET) in the management of lymphoma patients
Zinzani, P. L., Magagnoli, M., Chierichetti, F., Zompatori, M., Garraffa, G., Bendandi, M., Gherlinzoni, F., Cellini, C., Stefoni, V., Ferlin, G., et al. (1999) · Annals of Oncology · doi:10.1023/a:1008327127033 · Cited by 180
Role of [18F]Fluorodeoxyglucose Positron Emission Tomography Scan in the Follow-Up of Lymphoma
Luigi Zinzani, P., Stefoni, V., Tani, M., Fanti, S., Musuraca, G., Castellucci, P., Marchi, E., Fina, M., Ambrosini, V., Pellegrini, C., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.1513 · Cited by 173
Spaepen, K., Stroobants, S., Dupont, P., Thomas, J., Vandenberghe, P., Balzarini, J., De Wolf‐Peeters, C., Mortelmans, L., & Verhoef, G. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.03169.x · Cited by 169
Kostakoglu, L., Goldsmith, S. J., Leonard, J. P., Christos, P., Furman, R. R., Atasever, T., Chandramouly, A., Verma, S., Kothari, P., & Coleman, M. (2006) · Cancer · doi:10.1002/cncr.22276 · Cited by 168
Noy, A., Schöder, H., Gönen, M., Weissler, M., Ertelt, K., Cohler, C., Portlock, C., Hamlin, P., & Yeung, H. W. D. (2009) · Annals of Oncology · doi:10.1093/annonc/mdn657 · Cited by 166
Kaplan, W. D., Jochelson, M. S., Herman, T. S., Nadler, L. M., Stomper, P. C., Takvorian, T., Andersen, J. W., & Canellos, G. P. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.12.1966 · Cited by 161
Cerci, J. J., Pracchia, L. F., Linardi, C. C. G., Pitella, F. A., Delbeke, D., Izaki, M., Trindade, E. M., Soares, J., Buccheri, V., & Meneghetti, J. C. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.073197 · Cited by 157
Han, H. S., Escalón, M. P., Hsiao, B., Serafini, A. N., & Lossos, I. S. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn629 · Cited by 154
Herrmann, K., Wieder, H. A., Buck, A. K., Schöffel, M., Krause, B., Fend, F., Schuster, T., Büschenfelde, C. M. Z., Wester, H., Duyster, J., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-3025 · Cited by 153
Value of follow-up procedures in patients with large-cell lymphoma who achieve a complete remission.
Weeks, J. C., Yeap, B. Y., Canellos, G. P., & Shipp, M. A. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.7.1196 · Cited by 149
Zinzani, P. L., Tani, M., Fanti, S., Alinari, L., Musuraca, G., Marchi, E., Stefoni, V., Castellucci, P., Fina, M., Farshad, M., et al. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl122 · Cited by 149
Moulin-Romsee, G., Hindié, E., Cuenca, X., et al. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-009-1377-5 · Cited by 143
Direct Comparison of FDG PET and CT Findings in Patients with Lymphoma: Initial Experience
Tatsumi, M., Cohade, C., Nakamoto, Y., Fishman, E. K., & Wahl, R. L. (2005) · Radiology · doi:10.1148/radiol.2373040555 · Cited by 138
Rodríguez‐Vigil, B., León, N. G., Pinilla, I., Hernández‐Maraver, D., Coya, J., Curto, L. M. M., & Madero, R. (2006) · PubMed · Cited by 133
Horning, S. J., Juweid, M. E., Schöder, H. M., Wiseman, G. A., McMillan, A., Swinnen, L. J., Advani, R. H., Gascoyne, R. D., & Quon, A. S. W. (2009) · Blood · doi:10.1182/blood-2009-08-234351 · Cited by 121
Elstrom, R., Leonard, J. P., Coleman, M., & Brown, R. K. J. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn282 · Cited by 120
18-FDG-PET for the assessment of residual masses on CT following treatment of lymphomas
Mikhaeel, N. G., Timothy, A. R., Hain, S. F., & O'Doherty, M. J. (2000) · Annals of Oncology · doi:10.1093/annonc/11.suppl_1.s147 · Cited by 114
Liedtke, M., Hamlin, P. A., Moskowitz, C. H., & Zelenetz, A. D. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl049 · Cited by 103
Avigdor, A., Bulvik, S., Levi, I., Dann, E. J., Shem‐Tov, N., Perez‐Avraham, G., Shimoni, A., Nagler, A., Ben‐Bassat, I., & Polliack, A. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp271 · Cited by 102
Castellucci, P., Nanni, C., Farsad, M., Alinari, L., Zinzani, P. L., Stefoni, V., Battista, G., Valentini, D., Pettinato, C., Marengo, M., et al. (2005) · Nuclear Medicine Communications · doi:10.1097/01.mnm.0000171781.11027.bb · Cited by 96
Sugawara, Y., Zasadny, K. R., Kison, P. V., Baker, L. H., & Wahl, R. L. (1999) · PubMed · Cited by 94
Weng, L., Noy, A., YEUNG, H. W. D., et al. (2005) · Cited by 94
Bangerter, J. K. M. M. (1999) · Acta Oncologica · doi:10.1080/028418699432969 · Cited by 90
Dupuis, J., Itti, E., Rahmouni, A., Hémery, F., Gisselbrecht, C., Lin, C. K.-J., Copie‐Bergman, C., Belhadj, K., Gnaoui, T. E., Gaillard, I., et al. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn671 · Cited by 81
Cerci, J. J., Trindade, E. M., Pracchia, L. F., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.4367 · Cited by 78
Kasamon, Y. L., Wahl, R., Ziessman, H., Blackford, A., Goodman, S., Fidyk, C., Rogers, K. M., Bolaños-Meade, J., Borowitz, M., Ambinder, R., et al. (2009) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2008.11.026 · Cited by 64
Midtreatment 18F‐fluorodeoxyglucose positron‐emission tomography in aggressive non‐Hodgkin lymphoma
Zinzani, P. L., Gandolfi, L., Broccoli, A., Argnani, L., Fanti, S., Pellegrini, C., Stefoni, V., Derenzini, E., Quirini, F., & Baccarani, M. (2010) · Cancer · doi:10.1002/cncr.25579 · Cited by 64
Vose, J. M., Bierman, P. J., Anderson, J. R., Harrison, K., Dalrymple, G. V., Byar, K., Kessinger, A., & Armitage, J. O. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.9.2473 · Cited by 64
Marková, J., Kobe, C., Skopalová, M., Klásková, K., Dědečková, K., Plütschow, A., Eich, H. T., Dietlein, M., Engert, A., & Kozák, T. (2009) · Annals of Oncology · doi:10.1093/annonc/mdn768 · Cited by 52
Petrausch, U., Samaras, P., Veit‐Haibach, P., Tschopp, A., Soyka, J. D., Knuth, A. K., Hany, T. F., Mischo, A., Renner, C., & Schaefer, N. G. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp519 · Cited by 45
Goswami, T., Siddique, S. K., Cohen, P. R., & Cheson, B. D. (2010) · Clinical Lymphoma Myeloma & Leukemia · doi:10.3816/clml.2010.n.052 · Cited by 38
Self-citation
Cited by
Cheson, B. D., Fisher, R. I., Barrington, S. F., Cavalli, F., Schwartz, L. H., Zucca, E., & Lister, T. A. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.8800 · Cited by 5,715
Self-citationBarrington, S. F., Mikhaeel, N. G., Kostakoglu, L., Meignan, M., Hutchings, M., Müeller, S. P., Schwartz, L. H., Zucca, E., Fisher, R. I., Trotman, J., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.5229 · Cited by 1,665
Self-citationBreast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 4.2016
Ettinger, D. S., Wood, D. E., Akerley, W., Bazhenova, L. A., Borghaei, H., Camidge, D. R., Cheney, R. T., Chirieac, L. R., D'Amico, T. A., Dilling, T. J., et al. (2016) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2016.0031 · Cited by 736
Martelli, M., Ferreri, A. J. M., Agostinelli, C., Di Rocco, A., Pfreundschuh, M., & Pileri, S. A. (2013) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2012.12.009 · Cited by 456
Metadata
- Authors
- Cheson, B. D.
- Venue
- Journal of Clinical Oncology
- Published
- 2011-05-10
- Volume
- 29
- Issue
- 14
- Pages
- 1844-1854
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2149250280
- Cited by
- 280
- References
- 77
- FWCI
- 19.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.